However, there was no significant difference between non-O and O group, regarding PSA, Gleason score, clinical stage, lymph node involvement, or bone metastasis (p = 0.999, 0.234; p = 0.434; p = 0.232; p = 0.542; and p = 0.558, resp). Here, KLK3 is linked to bone metastasis.